<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220605055080N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-09-10</date_registration>
      <primary_sponsor>Esfahan University of Medical Sciences</primary_sponsor>
      <public_title>The effectiveness of a family-centered care on the aggression and Post-traumatic stress disorder (PTSD) in parents with congenital anomalies’ infants</public_title>
      <acronym></acronym>
      <scientific_title>The effectiveness of a family-centered care on the aggression and Post-traumatic stress disorder (PTSD) in parents with congenital anomalies’ infants</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-09-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>74</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/64784</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Not randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Other, Purpose: Education/Guidance, Other design features: The selected samples will be assigned to the control or intervention group by block randomization. This method will continue until the number of samples reaches the desired number of samples, Blinding description: Before starting the study, we will refer to the samples and explain the study to them, and after obtaining informed consent, they will be randomly assigned to the control or intervention group. Participants will not be informed whether the participant is currently in the intervention or control group. Also, the data will be coded so that the statistician will not be informed of the control or intervention group of the data.</study_design>
      <phase>4</phase>
      <hc_freetext>Post-traumatic stress disorder.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: This group will be subjected to the intervention of the family-oriented educational-support program based on four steps (information exchange, self-efficacy promotion, self-confidence (self-esteem) and evaluation) during 5 sessions; In this way, providing daily training to parents in the form of caring for babies with abnormalities, participation in baby care, facilitating communication and mutual support of couples, and psychological training regarding the stress associated with the presence of fathers and mothers of babies with abnormalities hospitalized in the intensive care unit. will be. In addition, an educational pamphlet will be provided to them. Family-centered care will be done with the presence of parents and the researcher in the breastfeeding room and the neonatal intensive care unit next to the baby. The researcher will receive the necessary training for counseling from the research consultant. The phone and SMS system will be used during the study period to resolve the questions and concerns of the parents. Intervention 2: Control group: Parents of infants in the control group will receive routine care from the neonatal intensive care unit of Chamran, Al-Zahra and Imam Hossein (AS) hospitals in Isfahan, and no intervention will be performed on them. After the end of the intervention and one month after the end of the intervention, the Revised Weiss and Marmer Event Impact Questionnaire (IES-R) and the Spielberger Trait-State Anger Questionnaire (STAXI-2) will be completed for mothers in each control group. The phone and SMS system will be used during the study period to solve the questions and concerns of parents.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is There is no further information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Fateme Vaez</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Forozan 8th Alley,  Arghvan St, Ferdowsi Square, Goldasht East.</address>
        <city>Khorramabad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6819765996</zip>
        <telephone>+98 66 3341 8247</telephone>
        <email>fateme0vaez@gmail.com</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Faramarz Kalhor</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Nursing and Midwifery College, Isfahan University of Medical Sciences and Health Services, Hazar Jarib St.</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8174673461</zip>
        <telephone>+98 31 3668 7153</telephone>
        <email>kalhor.faramarz@yahoo.com</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Post-traumatic stress disorder score above 24
Parents with a baby with any congenital abnormality requiring hospitalization in the neonatal intensive care unit
Literate to read and write
Parents without any mental disorder or history of taking psychiatric drugs
Absence History of substance abuse in parents</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Death of the baby during the intervention
Congenital abnormalities requiring emergency surgery
Discharge of the baby during the intervention
Occurrence of a stressful incident while studying
Absence and non-participation of parents in 1 or more sessions
Dissatisfaction and unwillingness of the baby's family to continue cooperating with the researcher at every stage of the study</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F43.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Post-traumatic stress disorder (PTSD)</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Other</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: This group will be subjected to the intervention of the family-oriented educational-support program based on four steps (information exchange, self-efficacy promotion, self-confidence (self-esteem) and evaluation) during 5 sessions; In this way, providing daily training to parents in the form of caring for babies with abnormalities, participation in baby care, facilitating communication and mutual support of couples, and psychological training regarding the stress associated with the presence of fathers and mothers of babies with abnormalities hospitalized in the intensive care unit. will be. In addition, an educational pamphlet will be provided to them. Family-centered care will be done with the presence of parents and the researcher in the breastfeeding room and the neonatal intensive care unit next to the baby. The researcher will receive the necessary training for counseling from the research consultant. The phone and SMS system will be used during the study period to resolve the questions and concerns of the parents.</i_keyword>
      <i_keyword>Control group: Parents of infants in the control group will receive routine care from the neonatal intensive care unit of Chamran, Al-Zahra and Imam Hossein (AS) hospitals in Isfahan, and no intervention will be performed on them. After the end of the intervention and one month after the end of the intervention, the Revised Weiss and Marmer Event Impact Questionnaire (IES-R) and the Spielberger Trait-State Anger Questionnaire (STAXI-2) will be completed for mothers in each control group. The phone and SMS system will be used during the study period to solve the questions and concerns of parents.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The average score of post-traumatic stress disorder changes in parents of babies with congenital malformation is different in the control and test groups after the intervention. Timepoint: before the start of the intervention and one month after the end of the intervention. Method of measurement: Revised Weiss and Marmer Impact of Event Questionnaire (IES-R).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>The average score of aggression changes in the parents of babies with congenital anomalies is different in the control and test groups after the intervention. Timepoint: before the start of the intervention and one month after the end of the intervention. Method of measurement: Spielberger Trait Anger Questionnaire (STAXI-2).</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Esfahan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-08-27</approval_date>
        <contact_name>Ethics committee of Isfahan University of Medical Sciences</contact_name>
        <contact_address>Central headquarters, Isfahan University of Medical Sciences and Health Services, Hazar Jarib St. Isfahan Isfehan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
